Analyzing Ainos (NASDAQ:AIMD) & Quantum Computing (NASDAQ:QUBT)

Quantum Computing (NASDAQ:QUBT) and Ainos (NASDAQ:AIMD) are both small-cap technology companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership and dividends.

Volatility & Risk

Quantum Computing has a beta of 3.74, indicating that its share price is 274% more volatile than the S&P 500. Comparatively, Ainos has a beta of 2.46, indicating that its share price is 146% more volatile than the S&P 500.

Earnings and Valuation

This table compares Quantum Computing and Ainos”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Quantum Computing	$680,000.00	2,816.06	-$15.84 million	($0.07)	-120.86
Ainos	$120,000.00	89.17	-$14.77 million	($2.52)	-0.58

Ainos has lower revenue, but higher earnings than Quantum Computing. Quantum Computing is trading at a lower price-to-earnings ratio than Ainos, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of current recommendations and price targets for Quantum Computing and Ainos, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Quantum Computing	1	2	4	0	2.43
Ainos	1	0	0	0	1.00

Quantum Computing currently has a consensus target price of $18.33, indicating a potential upside of 116.71%. Given Quantum Computing’s stronger consensus rating and higher probable upside, research analysts clearly believe Quantum Computing is more favorable than Ainos.

Institutional and Insider Ownership

4.3% of Quantum Computing shares are owned by institutional investors. 12.4% of Quantum Computing shares are owned by company insiders. Comparatively, 9.8% of Ainos shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Quantum Computing and Ainos’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Quantum Computing	N/A	N/A	N/A
Ainos	-11,912.10%	-217.50%	-67.87%

Summary

Quantum Computing beats Ainos on 12 of the 14 factors compared between the two stocks.

About Quantum Computing

Quantum Computing Inc., an integrated photonics company, offers accessible and affordable quantum machines. The company offers Dirac systems are portable, low power, and room temperature qubit and qudit entropy quantum computers (EQC); reservoir computing; remote sensing; and single photon imaging. It also provides Quantum random number generator (uQRNG), a portable device that provides genuine random numbers directly from quantum processes; and quantum authentication which eliminates vulnerabilities inherent in classical cryptographic schemes by offering a comprehensive entanglement-based quantum cyber solution that seamlessly integrates into existing telecom fiber and communication infrastructure. The company was formerly known as Innovative Beverage Group Holdings, Inc. Quantum Computing, Inc. was incorporated in 2018 and is based in Hoboken, New Jersey.

About Ainos

Ainos, Inc., a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. It also provides women’s health, pneumonia, Ainos Pen, AI Nose, and other products. Ainos, Inc. was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. The company was incorporated in 1984 and is based in San Diego, California.